介绍在印度,世界上人口最多和发展迅速的国家之一,至关重要的是优先考虑使用安全有效的避孕方法,因为避孕策略在促进社区健康方面发挥着关键作用。众所周知,确保适当的怀孕时间和间隔对生殖健康至关重要,母性,新生儿,孩子,和青少年健康。采用可逆的或间隔的避孕方法可以显著提高妇女的健康结果,减少不需要的,紧密定时,和错误的怀孕时机。因此,为了应对印度对可靠避孕的迫切需求,这项研究旨在评估接受度,坚持,以及可注射避孕储库醋酸甲羟孕酮(DMPA)在其使用者中的副作用。方法这项前瞻性观察性研究于2022年7月至2022年10月在泰米尔纳德邦Cuddalore区的州政府Taluk医院进行。通过目的抽样方法招募了40名选择DMPA作为避孕方法并符合纳入标准的育龄妇女。使用结构化问卷收集数据。结果大多数参与者是21-25岁的女性(n=14;35%)。参与者主要是印度教徒(n=39;97.5%),35人(87.5%)完成了高中教育。所有参与者(n=40;100%)居住在农村地区,大多数是家庭主妇。相当比例的参与者有两个孩子(n=21;52.5%),他们都主要从卫生人员那里收到了关于DMPA的信息。在数据收集的初始点,其中四分之三服用了第一剂(n=13;32.5%),只有少数服用了三剂以上(n=3;7.5%)。第三个月,结果显示DMPA使用量下降,这表明依从性较低,特别是与不规则出血(n=15;37.5%)和闭经(n=9;22.5%)等副作用有关。此外,35(87.5%)的妇女由于其功效和便利性而选择了DMPA作为生育间隔,在产后(n=4;10%)和流产后(n=1;2.5%)期间很少启动它。继续使用DMPA的原因包括疗效(n=20;50%),谨慎使用(n=15;37.5%),和好奇心(n=13;32.5%)。一半的参与者报告没有副作用。该研究确定了DMPA使用者与在世儿童数量和职业状况之间的关联,推断DMPA避孕药用于间隔生育。结论本研究结果表明,农村妇女对注射避孕药DMPA的使用和依从性有待加强。因此,这项研究建议纳入信息,教育,和沟通策略,提高农村妇女对注射避孕药的认识。
Introduction In India, one of the world\'s most populous and swiftly growing countries, it is crucial to prioritize the utilization of safe and effective contraception, as contraceptive strategies play a pivotal role in bolstering community health. It is widely acknowledged that ensuring appropriate timing and spacing of pregnancies is crucial for the well-being of reproductive, maternal, neonatal, child, and adolescent health. Adoption of reversible or spacing contraceptive methods can significantly enhance women\'s health outcomes by reducing the occurrence of undesired, closely timed, and mistimed pregnancies. Consequently, in response to the pressing need for dependable contraception in India, this
study seeks to assess the acceptance, adherence, and side effects of the injectable contraceptive depot medroxyprogesterone acetate (DMPA) among its users. Methods This prospective observational
study was done at the State Government Taluk Hospital in the Cuddalore District of Tamil Nadu from July 2022 to October 2022. A total of 40 women of reproductive age who opted for DMPA as their contraceptive method and met the inclusion criteria were recruited through a purposive sampling method. A structured questionnaire was used to collect the data. Results The majority of the participants were women aged 21-25 years (n=14; 35%). The participants were predominantly Hindu (n=39; 97.5%), and 35 (87.5%) had completed higher secondary education. All participants (n=40; 100%) resided in rural areas and the majority were homemakers. A significant proportion of the participants had two children (n=21; 52.5%), and all of them received information on DMPA primarily from health personnel. At the initial point of data collection, three-fourths of them took the first dose (n=13; 32.5%) and only a few took more than three doses (n=3; 7.5%). In the third month, the results showed a drop in DMPA use, which indicates a lower adherence particularly linked to side effects like irregular bleeding (n=15; 37.5%) and amenorrhea (n=9; 22.5%). Furthermore, 35 (87.5%) of the women chose DMPA for birth spacing due to its efficacy and convenience, with few initiating it during postpartum (n=4; 10%) and post-abortal (n=1; 2.5%) periods. The reasons for continuing DMPA use included efficacy (n=20; 50%), discreet usage (n=15; 37.5%), and curiosity (n=13; 32.5%). Half of the participants reported no side effects. The
study identified associations between DMPA users and the number of living children and occupational status inferring that DMPA contraception is used for spacing births. Conclusion The results of this
study imply that the use and adherence to injectable contraceptive DMPA need to be strengthened among rural women. Thus, the
study suggests incorporating information, education, and communication strategies, to enhance awareness among rural women about injectable contraceptives.